Welcome to the GoodRx third-quarter 2024 earnings call. As a reminder, today's conference call is being recorded. I would now ...

Our results were released earlier this morning, and the press release and charts have been posted to our website ... Within our life sciences vertical, we're seeing the investment in GLP-1 drugs as ...

Q4 2024 Earnings Call Transcript November 7, 2024 Operator: Thank you for holding, and welcome to Rockwell Automation’s ...

Total company orders grew 10% or up 1% organically, finishing largely in ... As illustrated in the chart on the left hand side of the page, our MQLs continue to grow. For the quarter, organic ...

Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers discovered. Advertisement Under the Medicaid system ...

Smoothie King, a franchise that specializes in selling smoothies, recently launched a "GLP-1 Support Menu." The new menu was made specifically for people who take GLP-1 drugs like Ozempic and Wegovy.

GLP-1 RAs can decrease the risk for developing early-onset colorectal cancer (EO-CRC) in patients with diabetes regardless of weight.

On November 5, the US Food and Drug Administration (FDA) updated the labels for all glucagon-like peptide 1 receptor agonists (GLP-1 RA) with a warning about pulmonary aspiration during general ...

Intense competition from Viking Therapeutics and Amgen, may result in a new best in class GLP-1 drug, further threatening ... but as can be seen in the above chart they are relatively negligible ...

Glucagon-like peptide-1 (GLP-1) drugs can help you lose weight and manage type 2 diabetes. Whether you buy these medications online or in person, it is important to get a prescription from ...

Nov 1 (Reuters) - In a practice-changing guideline reversal, medical societies advised, opens new tab on Tuesday that most patients do not need to stop taking GLP-1 diabetes and weight-loss drugs ...